--- name: confidentiality-nda title: Confidentiality Agreement (NDA) description: Drafts enforceable confidentiality and non-disclosure agreements for corporate transactions, M&A, partnerships, and due diligence. Covers mutual and unilateral structures, defined-term confidential information, permitted disclosures, non-solicitation, standstill, return/destruction obligations, and equitable remedies. Use when drafting an NDA, confidentiality agreement, or mutual confidentiality agreement for business transactions. author: CaseMark author_url: https://github.com/CaseMark/skills/tree/main/skills/legal/confidentiality-nda license: Apache-2.0 version: 0.1.0 execution_mode: open jurisdiction: general practice: contracts language: en --- # Confidentiality Agreement (NDA) Drafts professional-grade NDAs for corporate transactions, M&A, partnerships, and sensitive business discussions. Supports mutual and unilateral structures. ## Quick Start Gather before drafting: 1. **Parties** — legal names, entity types, addresses; clarify subsidiary/parent relationships 2. **Transaction type** — acquisition, JV, licensing, partnership, or exploratory 3. **Direction** — mutual (both disclose) or unilateral (one-way) 4. **Sensitivity** — determines care standard, duration, standstill/non-solicit need 5. **Governing law** — jurisdiction for choice of law and venue ## Core Workflow ### 1. Header & Recitals - Title reflects mutual vs. unilateral; reference transaction if applicable - Effective date: typically date of execution - State specific transaction type and permitted scope of use - Include: "No obligation to proceed with any transaction" ### 2. Definition of Confidential Information **Include:** financial data, business plans, customer/supplier lists, technical IP, personnel info, trade secrets, and the existence of discussions themselves. **Standard exclusions:** - Public domain at time of disclosure or becomes public without breach - Already in receiving party's possession (written evidence required) - Independently developed (contemporaneous written records required) - Received from non-obligated third party All information qualifies regardless of marking. Best practice: mark written materials, confirm oral disclosures in writing within a reasonable period. ### 3. Obligations & Permitted Disclosures **Core obligations:** - Use solely for evaluating the stated transaction — no competitive use - Care standard: same as own confidential info, no less than reasonable care - No third-party disclosure without prior written consent **Permitted representatives** (need-to-know only): officers, directors, involved employees, attorneys, accountants, financial advisors, consultants. Representatives must be informed of obligations and bound by terms at least as restrictive. Receiving party is liable for representative breaches. **Compelled disclosure:** prompt written notice to disclosing party, cooperate to limit scope, disclose minimum required, seek confidential treatment. ### 4. Protective Provisions **Non-solicitation** (when appropriate): covers employees contacted or learned about during evaluation. Typically 1–3 years. Includes direct and indirect solicitation. **Standstill** (acquisitions, especially public targets): prohibits acquiring securities, proposing mergers, proxy solicitation, forming shareholder groups. Typically 6 months–2 years. Exceptions: board consent, unsolicited proposals, third-party acquisition announcements. **No obligation to transact:** binding commitments arise only from definitive written agreements. LOIs and term sheets non-binding except provisions expressly designated. ### 5. Term & Return/Destruction - Confidentiality duration: 2–5 years (3 typical); trade secrets indefinite - On written request or termination: return or destroy all materials, copies, excerpts, analyses, and derivatives - Reasonable steps to delete electronic copies; backups remain subject to obligations - Written certification by authorized officer confirming compliance ### 6. IP, Remedies & Boilerplate **IP disclaimers:** no license or rights granted by disclosure; no representations on accuracy/completeness. **Remedies:** breach causes irreparable harm; equitable relief (TRO, injunction) available without bond, in addition to damages. Consider prevailing-party fees and liquidated damages. **Governing law:** specified state, without conflicts-of-law principles. Exclusive jurisdiction in chosen venue. Consider jury waiver or arbitration. **Standard boilerplate:** entire agreement, written amendments only, no waiver by conduct, severability with reformation, no assignment without consent. ### 7. Execution Signature blocks: signature, printed name, title, date per party. Verify signatory authority. ## Pitfalls & Checks - **Mutual symmetry** — if mutual, all obligations must apply symmetrically to both parties - **Public companies** — address Regulation FD, insider trading, MNPI restrictions; coordinate standstill with securities counsel - **Cross-border** — address GDPR (EU parties), export controls, cross-border enforcement - **Electronic execution** — ensure E-SIGN Act / UETA compliance [VERIFY] - **Scope calibration** — exploratory partnerships need narrower terms than full M&A due diligence - **Do not** override legal compulsion to disclose (unenforceable) - **Do not** add standstill for private companies unless specifically requested